Yilmaz Y - Search Results

1

Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease.

Yilmaz Y, Eren F, Colak Y, Senates E, Celikel CA, Imeryuz N. Yilmaz Y, et al. Scand J Gastroenterol. 2012 Dec;47(12):1488-93. doi: 10.3109/00365521.2012.725093. Epub 2012 Nov 8. Scand J Gastroenterol. 2012. PMID: 23137022

2

Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease.

Yilmaz Y, Ulukaya E, Gul OO, Arabul M, Gul CB, Atug O, Oral AY, Aker S, Dolar E. Yilmaz Y, et al. Clin Biochem. 2009 Jun;42(9):802-7. doi: 10.1016/j.clinbiochem.2009.02.003. Epub 2009 Feb 13. Clin Biochem. 2009. PMID: 19217891

3

Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease.

Yilmaz Y, Atug O, Yonal O, Duman D, Ozdogan O, Imeryuz N, Kalayci C. Yilmaz Y, et al. Med Sci Monit. 2009 Apr;15(4):HY1-5. Med Sci Monit. 2009. PMID: 19333209

4

Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance.

Yilmaz Y, Ulukaya E, Atug O, Dolar E. Yilmaz Y, et al. Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1247-51. doi: 10.1097/MEG.0b013e32832b77ae. Eur J Gastroenterol Hepatol. 2009. PMID: 19474742

5

Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.

Tiftikci A, Atug O, Yilmaz Y, Eren F, Ozdemir FT, Yapali S, Ozdogan O, Celikel CA, Imeryuz N, Tozun N. Tiftikci A, et al. Among authors: yilmaz y. Arch Med Res. 2009 May;40(4):294-8. doi: 10.1016/j.arcmed.2009.04.008. Arch Med Res. 2009. PMID: 19608019

6

Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis.

Yilmaz Y, Kedrah AE, Ozdogan O. Yilmaz Y, et al. World J Gastroenterol. 2009 Sep 21;15(35):4387-91. doi: 10.3748/wjg.15.4387. World J Gastroenterol. 2009. PMID: 19764089 Free PMC article. Review.

7

Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Ulukaya E, Yilmaz Y, Moshkovskii S, Karpova M, Pyatnitskiy M, Atug O, Dolar E. Ulukaya E, et al. Among authors: yilmaz y. Scand J Gastroenterol. 2009;44(12):1471-6. doi: 10.3109/00365520903353379. Scand J Gastroenterol. 2009. PMID: 19883279

8

Metformin, hepatitis C, and insulin resistance: sufficient evidence?

Yilmaz Y, Yonal O, Imeryuz N. Yilmaz Y, et al. Hepatology. 2009 Dec;50(6):2054-5; author reply 2055. doi: 10.1002/hep.23359. Hepatology. 2009. PMID: 19937685 No abstract available.

9

Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis.

Yilmaz Y, Alahdab YO, Yonal O, Kurt R, Kedrah AE, Celikel CA, Ozdogan O, Duman D, Imeryuz N, Avsar E, Kalayci C. Yilmaz Y, et al. Metabolism. 2010 Sep;59(9):1327-30. doi: 10.1016/j.metabol.2009.12.012. Epub 2010 Jan 22. Metabolism. 2010. PMID: 20096896

10

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis.

Yilmaz Y, Kurt R, Yonal O, Polat N, Celikel CA, Gurdal A, Oflaz H, Ozdogan O, Imeryuz N, Kalayci C, Avsar E. Yilmaz Y, et al. Atherosclerosis. 2010 Jul;211(1):182-6. doi: 10.1016/j.atherosclerosis.2010.01.049. Epub 2010 Feb 7. Atherosclerosis. 2010. PMID: 20181335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

952 results

Search Page

Filters